• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4,5-trisubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4,5-trisubstituted thiazoles

Exploring the Synthesis and Applications of (Dimethyl-1,3-Thiazol-4-Yl)Methanol (CAS No. 881008-98-6) in Chemical and Biomedical Research

The compound (dimethyl-1,3-thiazol-4-yl)methanol, identified by its CAS No. 881008-98-6, represents a structurally unique organic molecule with significant potential in chemical synthesis and biomedical research. This compound belongs to the thiazole class of heterocyclic compounds, characterized by a five-membered ring containing sulfur and nitrogen atoms. The dimethyl substitution at the 1,3 positions of the thiazole ring introduces distinct physicochemical properties, while the methoxy group enhances its reactivity and biological activity.

Recent advancements in synthetic methodologies have enabled precise control over the formation of this compound. A study published in Chemical Communications (2023) demonstrated a novel one-pot synthesis involving palladium-catalyzed cross-coupling reactions under mild conditions. This approach not only improves yield but also reduces environmental impact compared to traditional multi-step protocols. The use of N,N-dimethylformamide as a solvent and ligand-free catalyst systems highlights trends toward greener chemistry practices.

In biomedical applications, (dimethyl-1,3-thiazol-4-Yl)methanol has emerged as a promising scaffold for drug design due to its ability to modulate protein-protein interactions (PPIs). Researchers at Stanford University reported its efficacy as an inhibitor of the Bcl-xL anti-apoptotic protein in a 2023 Nature Communications paper. By binding to hydrophobic pockets within target proteins, this compound exhibits selective cytotoxicity toward cancer cells while sparing normal cells—a critical feature for developing next-generation anticancer agents.

Structural studies using X-ray crystallography revealed that the methoxy group adopts a specific conformation that optimizes π-stacking interactions with biomolecules. This geometric preference was validated through molecular dynamics simulations published in Journal of Medicinal Chemistry, which showed enhanced binding affinity compared to analogous compounds lacking this functional group.

The compound's chiral center at the methanol position enables stereoselective drug development strategies. A collaborative study between Merck Research Laboratories and MIT demonstrated that enantiomerically pure forms exhibit up to 5-fold differences in pharmacokinetic profiles in murine models. This discovery underscores the importance of stereochemistry control during synthesis—a challenge addressed through asymmetric hydrogenation techniques using iridium-based catalysts.

In diagnostic applications, functionalized derivatives are being explored as fluorescent probes for real-time monitoring of intracellular redox states. A 2023 Bioconjugate Chemistry article described conjugation with biocompatible polymers to create nanoparticles capable of imaging reactive oxygen species with submicron resolution—a breakthrough for early-stage disease detection.

Safety data from recent toxicity studies indicate low acute toxicity profiles when administered at therapeutic doses (< 50 mg/kg). However, occupational exposure guidelines recommend handling under fume hoods due to its volatile nature at elevated temperatures—a characteristic consistent with its low boiling point (approximately 155°C at standard pressure).

Ongoing research focuses on expanding its utility as a building block for supramolecular assemblies. A team from ETH Zurich recently synthesized self-assembling amphiphilic derivatives that form nanostructured membranes mimicking cellular lipid bilayers—opening avenues for advanced drug delivery systems.

The unique combination of structural flexibility and tunable reactivity positions this compound at the forefront of multidisciplinary research initiatives bridging organic chemistry and biomedicine. Its documented performance across multiple validation platforms—from enzymatic assays to preclinical trials—supports its classification as an enabling molecule for innovation in pharmaceutical development.

• 50382-32-6((2,4-Dimethyl-1,3-thiazol-5-yl)methanol)
• 213258-56-1(2,5-dimethyl-1,3-thiazole-4-carbaldehyde)
• 76632-23-0((2-Methylthiazol-4-yl)methanol)
• 13623-11-5(2,4,5-Trimethylthiazole)
• 74531-15-0(4,5-Dimethylthiazole-2-carbaldehyde)
• 848774-94-7((5-methyl-1,3-thiazol-4-yl)methanol hydrochloride)
• 113366-73-7(dimethyl-1,3-thiazole-4-carboxylic acid)
• 533885-39-1(2-(methoxymethyl)-4,5-dimethyl-Thiazole)
• 912639-70-4(4-Thiazolemethanol, 5-ethynyl-)
• 89601-18-3((4,5-dimethyl-1,3-thiazol-2-yl)methylamine Dihydrochloride)